Acalabrutinib Metabolite (M27) ACP-5862 D4
| Chemical Name | Acalabrutinib Metabolite (M27) ACP-5862 D4 |
|---|---|
| Alternate Names | Acalabrutinib Stable Isotopes, Stable Isotopes of Acalabrutinib |
| CAT No. | CS-O-36984 |
| CAS Registry# | 2230757-47-6 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 485.53 g/mol |
| Mol. For. | C26H19D4N7O3 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Acalabrutinib |
| Smileys | O=C(NC1=NC([2H])=C([2H])C([2H])=C1[2H])C2=CC=C(C3=C4C(N)=NC=CN4C(C(CCCNC(C#CC)=O)=O)=N3)C=C2 |
| Canonical Smiles | CC#CC(=O)NCCCC(=O)C1=NC(=C2N1C=CN=C2N)C3=CC=C(C=C3)C(=O)NC4=CC=CC=N4 |
| InchIKey | XZAATUBTUPPERZ-UHFFFAOYSA-N |
| Inchl | InChI=1S/C26H23N7O3/c1-2-6-21(35)29-14-5-7-19(34)25-32-22(23-24(27)30-15-16-33(23)25)17-9-11-18(12-10-17)26(36)31-20-8-3-4-13-28-20/h3-4,8-13,15-16H,5,7,14H2,1H3,(H2,27,30)(H,29,35)(H,28,31,36) |
| IUPAC | 4-[8-amino-3-[4-(but-2-ynoylamino)butanoyl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Acalabrutinib Metabolite (M27) ACP-5862 D4 is a chemical compound that is used in the treatment of certain types of blood cancers. Specifically, it is a metabolite of Acalabrutinib, a drug that is used to treat mantle cell lymphoma and chronic lymphocytic leukemia. M27 is formed in the body when Acalabrutinib is metabolized, and it has been found to have similar activity to the parent drug.
Chemically, M27 is a deuterated form of ACP-5862, which is the active metabolite of Acalabrutinib. Deuterium is a heavy isotope of hydrogen, and its incorporation into the chemical structure of M27 can have beneficial pharmacological effects. For example, deuterated compounds may have improved stability and a longer half-life in the body, which can lead to more effective treatment.
In terms of usage, M27 is not directly administered as a drug. Rather, its presence in the body is used as an indicator of how Acalabrutinib is being metabolized and how effective the treatment is. Doctors may test for M27 levels in the blood of patients taking Acalabrutinib to determine if the drug is being metabolized properly and to adjust the dosage if necessary.
Overall, Acalabrutinib Metabolite (M27) ACP-5862 D4 is an important chemical compound in the treatment of certain blood cancers. Its chemical properties and role in the body make it a useful tool for doctors in monitoring the efficacy of Acalabrutinib treatment.
Get an Instant Quote
Related Compounds
Acalabrutinib intermediate D4 | Acalabrutinib-D4 | Acalabrutinib-d3 |